Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASLAN001 with CAPOX or mFolfox6 in Metastatic Solid Tumors
NCT02435927Phase 1Unknown
- Sponsor
- National Cancer Centre Singapore
- Start
- Aug 2014
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of varlitinib in solid tumor, sponsored by National Cancer Centre Singapore. Status: unknown.
02
Drugs
varlitinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02435927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02435927.